This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
PICO
Question: Among pregnant women, does universal urine drug testing at delivery compared to risk-based testing identify opioid-exposed infants who would otherwise have been missed?
Question type: Diagnosis
Study design: Retrospective cohort
Investigators from Cincinnati Children’s Hospital conducted a retrospective chart review to evaluate the efficacy of universal maternal drug testing to identify opioid-exposed infants. A single community hospital that provides high-risk maternity and level II nursery services adopted a hospital policy in which all pregnant women were screened on admission for delivery for drug substances in urine. The urine drug test detected the presence of 9 substances: amphetamines, barbiturates, benzodiazepine, cannabinoids, methadone, opiates, phencyclidine, propoxyphene, and cocaine metabolites. Buprenorphine …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.